• 1
    McGuire BM. The critically ill liver patient: fulminant hepatic failure. Semin Gastrointest Dis 2003; 14: 3942.
  • 2
    Heneghan MA, Lara L. Fulminant hepatic failure. Semin Gastrointest Dis 2003; 14: 87100.
  • 3
    Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U. Enhanced expression of CD80 (B7–1), CD86 (B7–2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol 1999; 154: 17111720.
  • 4
    Leifeld L, Dumoulin FL, Purr I, Janberg K, Trautwein C, Wolff M, et al. Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol 2003; 199: 335344.
  • 5
    Streetz K, Leifeld L, Grundmann D, Ramakers J, Eckert K, Spengler U, et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology 2000; 119: 446460.
  • 6
    van Kooten C, Banchereau J. CD40-CD40 ligand. J Leukoc Biol 2000; 67: 217.
  • 7
    Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, et al. Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003; 52: 14351441.
  • 8
    Renshaw BR, Fanslow WC 3rd, Armitage RJ, Campbell KA, Liggitt D, Wright B, et al. Humoral immune responses in CD40 ligand-deficient mice. J Exp Med 1994; 180: 18891900.
  • 9
    Castigli E, Alt FW, Davidson L, Bottaro A, Mizoguchi E, Bhan AK, et al. CD40-deficient mice generated by recombination-activating gene-2-deficient blastocyst complementation. Proc Natl Acad Sci U S A 1994; 91: 1213512139.
  • 10
    Bhushan A, Covey LR. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes. Immunol Res 2001; 24: 311324.
  • 11
    DeFina R, Christopher K, He H, Mandelbrot D, Gu Y, Finn P, et al. Analysis of costimulation by 4-1BBL, CD40L, and B7 in graft rejection by gene expression profiles. J Mol Med 2003; 81: 655663.
  • 12
    Pearson TC, Trambley J, Odom K, Anderson DC, Cowan S, Bray R, et al. Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation 2002; 74: 933940.
  • 13
    Jacobsohn DA. Novel therapeutics for the treatment of graft-versus-host disease. Expert Opin Investig Drugs 2002; 11: 12711280.
  • 14
    Gao D, Wagner AH, Fankhaenel S, Stojanovic T, Schweyer S, Panzner S, et al. CD40 antisense oligonucleotide inhibition of trinitrobenzene sulphonic acid induced rat colitis. Gut 2005; 54: 7077.
  • 15
    Schmitz V, Barajas M, Wang L, Peng D, Duarte M, Prieto J, et al. Adenovirus-mediated CD40 ligand gene therapy in a rat model of orthotopic hepatocellular carcinoma. HEPATOLOGY 2001; 34: 7281.
  • 16
    Sun Y, Peng D, Lecanda J, Schmitz V, Barajas M, Qian C, et al. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity. Gene Ther 2000; 7: 14671476.
  • 17
    Qian C, Bilbao R, Bruna O, Prieto J. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. HEPATOLOGY 1995; 22: 118123.
  • 18
    Kurata H, Liu CB, Valkova J, Koch AE, Yssel H, Hirabayashi Y, et al. Recombinant adenovirus vectors for cytokine gene therapy in mice. J Allergy Clin Immunol 1999; 103: S471S484.
  • 19
    Huard J, Lochmuller H, Acsadi G, Jani A, Massie B, Karpati G. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants. Gene Ther 1995; 2: 107115.
  • 20
    Zender L, Hutker S, Liedtke C, Tillmann HL, Zender S, Mundt B, et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc Natl Acad Sci U S A 2003; 100: 77977802.
  • 21
    Vonderheide RH, Dutcher JP, Anderson JE, Eckhardt SG, Stephans KF, Razvillas B, et al. Phase I study of recombinant human CD40 ligand in cancer patients. J Clin Oncol 2001; 19: 32803287.
  • 22
    Mehling A, Loser K, Varga G, Metze D, Luger TA, Schwarz T, et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J Exp Med 2001; 194: 615628.
  • 23
    Zhou F, Ajuebor MN, Beck PL, Le T, Hogaboam CM, Swain MG. CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis. HEPATOLOGY 2005; 42: 372380.